This metabolic reconfiguration, prompted by NF-κB inhibition, circumvents the necessity for mutations in tumor suppressor genes, a common requirement in oncogenic transformation, and attenuates the metabolic adaptability of cancer cells in physiological settings. Here, NFKB1 is linked to neoplasm.